|
1
|
Garg K, Karnezis AN and Rabban JT:
Uncommon hereditary gynaecological tumour syndromes: Pathological
features in tumours that may predict risk for a germline mutation.
Pathology. 50:238–256. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Seagle BL, Alexander AL, Lantsman T and
Shahabi S: Prognosis and treatment of positive peritoneal cytology
in early endometrial cancer: Matched cohort analyses from the
National Cancer Database. Am J Obstet Gynecol. 218:329.e1–329.e15.
2018. View Article : Google Scholar
|
|
3
|
Pal N, Broaddus RR, Urbauer DL,
Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu
KH, Ramirez PT, et al: Treatment of low-risk endometrial cancer and
complex atypical hyperplasia with the levonorgestrel-releasing
intrauterine device. Obstet Gynecol. 131:109–116. 2018.PubMed/NCBI
|
|
4
|
Troisi J, Sarno L, Landolfi A, Scala G,
Martinelli P, Venturella R, Di Cello A, Zullo F and Guida M:
Metabolomic signature of endometrial cancer. J Proteome Res.
17:804–812. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smith D, Stewart CJR, Clarke EM, Lose F,
Davies C, Armes J, Obermair A, Brennan D, Webb PM, Nagle CM, et al:
ER and PR expression and survival after endometrial cancer. Gynecol
Oncol. 148:258–266. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gibson DA, Collins F, Cousins FL, Esnal
Zufiaurre A and Saunders PT: The impact of 27-hydroxycholesterol on
endometrial cancer proliferation. Endocr Relat Cancer. 25:381–391.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cho K, Havelock JC, Gilks B and Dunne C:
Case report: An identical twin with Sertoli-Leydig cell tumor.
Gynecol Endocrinol. 34:563–566. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Deguine C and Pulec JL: Attic
cholesteatoma and tympanosclerosis. Ear Nose Throat J. 76:3641997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wen KC, Sung PL, Chou YT, Pan CM, Wang PH,
Lee OK and Wu CW: The role of EpCAM in tumor progression and the
clinical prognosis of endometrial carcinoma. Gynecol Oncol.
148:383–392. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hou R, Yao SS, Liu J, Wang LL, Wu L and
Jiang L: Dietary n-3 polyunsaturated fatty acids, fish consumption,
and endometrial cancer risk: A meta-analysis of epidemiological
studies. Oncotarget. 8:91684–91693. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qiao Q and Li H: LncRNA FER1L4 suppresses
cancer cell proliferation and cycle by regulating PTEN expression
in endometrial carcinoma. Biochem Biophys Res Commun. 478:507–512.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Williams E, Villar-Prados A, Bowser J,
Broaddus R and Gladden AB: Loss of polarity alters proliferation
and differentiation in low-grade endometrial cancers by disrupting
Notch signaling. PLoS One. 12:e01890812017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maybin JA, Murray AA, Saunders PT, Hirani
N, Carmeliet P and Critchley HO: Hypoxia and hypoxia inducible
factor-1α are required for normal endometrial repair during
menstruation. Nat Commun. 9:2952018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Knific T, Vouk K, Smrkolj Š, Prehn C,
Adamski J and Rižner TL: Models including plasma levels of
sphingomyelins and phosphatidylcholines as diagnostic and
prognostic biomarkers of endometrial cancer. J Steroid Biochem Mol
Biol. 178:312–321. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Beck TL, Schiff MA, Goff BA and Urban RR:
Robotic, laparoscopic, or open hysterectomy: Surgical outcomes by
approach in endometrial cancer. J Minim Invasive Gynecol.
25:986–993. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ebeid K, Meng X, Thiel KW, Do AV, Geary
SM, Morris AS, Pham EL, Wongrakpanich A, Chhonker YS, Murry DJ, et
al: Synthetically lethal nanoparticles for treatment of endometrial
cancer. Nat Nanotechnol. 13:72–81. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pihlajamäki J, Lerin C, Itkonen P, Boes T,
Floss T, Schroeder J, Dearie F, Crunkhorn S, Burak F,
Jimenez-Chillaron JC, et al: Expression of the splicing factor gene
SFRS10 is reduced in human obesity and contributes to enhanced
lipogenesis. Cell Metab. 14:208–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grellscheid SN, Dalgliesh C, Rozanska A,
Grellscheid D, Bourgeois CF, Stévenin J and Elliott DJ: Molecular
design of a splicing switch responsive to the RNA binding protein
Tra2β. Nucleic Acids Res. 39:8092–8104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hirschfeld M, Jaeger M, Buratti E, Stuani
C, Grueneisen J, Gitsch G and Stickeler E: Expression of
tumor-promoting Cyr61 is regulated by hTRA2-β1 and acidosis. Hum
Mol Genet. 20:2356–2365. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Elks CE, Perry JR, Sulem P, Chasman DI,
Franceschini N, He C, Lunetta KL, Visser JA, Byrne EM, Cousminer
DL, et al GIANT Consortium, : Thirty new loci for age at menarche
identified by a meta-analysis of genome-wide association studies.
Nat Genet. 42:1077–1085. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mende Y, Jakubik M, Riessland M, Schoenen
F, Rossbach K, Kleinridders A, Köhler C, Buch T and Wirth B:
Deficiency of the splicing factor Sfrs10 results in early embryonic
lethality in mice and has no impact on full-length SMN/Smn
splicing. Hum Mol Genet. 19:2154–2167. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Benderska N, Becker K, Girault JA, Becker
CM, Andreadis A and Stamm S: DARPP-32 binds to tra2-beta1 and
influences alternative splicing. Biochim Biophys Acta.
1799:448–453. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grellscheid S, Dalgliesh C, Storbeck M,
Best A, Liu Y, Jakubik M, Mende Y, Ehrmann I, Curk T, Rossbach K,
et al: Identification of evolutionarily conserved exons as
regulated targets for the splicing activator tra2β in development.
PLoS Genet. 7:e10023902011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gabriel B, Zur Hausen A, Bouda J, Boudova
L, Koprivova M, Hirschfeld M, Jager M and Stickeler E: Significance
of nuclear hTra2-beta1 expression in cervical cancer. Acta Obstet
Gynecol Scand. 88:216–221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Watermann DO, Tang Y, Zur Hausen A, Jäger
M, Stamm S and Stickeler E: Splicing factor Tra2-beta1 is
specifically induced in breast cancer and regulates alternative
splicing of the CD44 gene. Cancer Res. 66:4774–4780. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang M, Li L, Wang J, Gao T, Sun Y, Li H,
Tong X and Ouyang Y: Heterogeneous nuclear ribonucleoproteins
(hnRNPs) and human transformer-2-beta1 (hTra2-beta1)-regulated
estrogen receptor-alpha improves prognosis of endometrial cancer.
Eur J Gynaecol Oncol. 35:701–707. 2014.PubMed/NCBI
|
|
27
|
Akaike Y, Masuda K, Kuwano Y, Nishida K,
Kajita K, Kurokawa K, Satake Y, Shoda K, Imoto I and Rokutan K: HuR
regulates alternative splicing of the TRA2β gene in human colon
cancer cells under oxidative stress. Mol Cell Biol. 34:2857–2873.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kajita K, Kuwano Y, Satake Y, Kano S,
Kurokawa K, Akaike Y, Masuda K, Nishida K and Rokutan K:
Ultraconserved region-containing Transformer 2β4 controls
senescence of colon cancer cells. Oncogenesis. 5:e2132016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Munkley J, Livermore K, Rajan P and
Elliott DJ: RNA splicing and splicing regulator changes in prostate
cancer pathology. Hum Genet. 136:1143–1154. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Petru E, Lück HJ, Stuart G, Gaffney D,
Millan D and Vergote I; Gynecologic Cancer Intergroup (GCIG), :
Gynecologic Cancer Intergroup (GCIG) proposals for changes of the
current FIGO staging system. Eur J Obstet Gynecol Reprod Biol.
143:69–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang QW, Su Y, Sheng JT, Gu LM, Zhao Y,
Chen XX, Chen C, Li WZ, Li KS and Dai JP: Anti-influenza A virus
activity of rhein through regulating oxidative stress, TLR4, Akt,
MAPK, and NF-kappaB signal pathways. PLoS One. 13:e01917932018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gu Y, Zhang J and Guan H: Expression of
EZH2 in endometrial carcinoma and its effects on proliferation and
invasion of endometrial carcinoma cells. Oncol Lett. 14:7191–7196.
2017.PubMed/NCBI
|
|
34
|
Zhang J, Pi J, Liu Y, Yu J and Feng T:
Knockdown of YTH N6-methyladenosine RNA binding protein 2 (YTHDF2)
inhibits proliferation and promotes apoptosis in MGC-803 gastric
cancer cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 33:1628–1634.
2017.(In Chinese). PubMed/NCBI
|
|
35
|
Liu J, Qu X, Shao L, Hu Y, Yu X, Lan P,
Guo Q, Han Q, Zhang J and Zhang C: Pim-3 enhances melanoma cell
migration and invasion by promoting STAT3 phosphorylation. Cancer
Biol Ther. 19:160–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grilz E, Marosi C, Königsbrügge O, Riedl
J, Posch F, Lamm W, Lang IM, Pabinger I and Ay C: Association of
complete blood count parameters, d-Dimer and soluble P-selectin
with risk of arterial thromboembolism in patients with cancer. J
Thromb Haemost. May 17–2019.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Song D, Powles T, Shi L, Zhang L,
Ingersoll MA and Lu YJ: Bladder cancer, a unique model to
understand cancer immunity and develop immunotherapy approaches. J
Pathol. May 18–2019.(Epub ahead of print). View Article : Google Scholar
|
|
38
|
Meerson A, Eliraz Y, Yehuda H, Knight B,
Crundwell M, Ferguson D, Lee BP and Harries LW: Obesity impacts the
regulation of miR-10b and its targets in primary breast tumors. BMC
Cancer. 19:862019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang S, Wang J, Ghoshal T, Wilkins D, Mo
YY, Chen Y and Zhou Y: lncRNA gene signatures for prediction of
breast cancer intrinsic subtypes and prognosis. Genes (Basel).
9:92018. View Article : Google Scholar
|
|
40
|
Fialkova V, Vidomanova E, Balharek T,
Marcinek J, Kudela E, Hanysova S, Visnovsky J, Dobrota D and Hatok
J: DNA methylation as mechanism of apoptotic resistance development
in endometrial cancer patients. Gen Physiol Biophys. 36:521–529.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ma R, Feng N, Yu X, Lin H, Zhang X, Shi O,
Zhang H, Zhang S, Li L, Zheng M, et al: Promoter methylation of
Wnt/β-Catenin signal inhibitor TMEM88 is associated with
unfavorable prognosis of non-small cell lung cancer. Cancer Biol
Med. 14:377–386. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Martinez-Garcia E, Lesur A, Devis L,
Campos A, Cabrera S, van Oostrum J, Matias-Guiu X, Gil-Moreno A,
Reventos J, Colas E, et al: Development of a sequential workflow
based on LC-PRM for the verification of endometrial cancer protein
biomarkers in uterine aspirate samples. Oncotarget. 7:53102–53115.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen X, Huang J, Li J, Han Y, Wu K and Xu
P: Tra2betal regulates P19 neuronal differentiation and the
splicing of FGF-2R and GluR-B minigenes. Cell Biol Int. 28:791–799.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shiraishi E, Imazato H, Yamamoto T, Yokoi
H, Abe S and Kitano T: Identification of two teleost homologs of
the Drosophila sex determination factor, transformer-2 in
medaka (Oryzias latipes). Mech Dev. 121:991–996. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Stoilov P, Daoud R, Nayler O and Stamm S:
Human tra2-beta1 autoregulates its protein concentration by
influencing alternative splicing of its pre-mRNA. Hum Mol Genet.
13:509–524. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hofmann Y and Wirth B: hnRNP-G promotes
exon 7 inclusion of survival motor neuron (SMN) via direct
interaction with Htra2-beta1. Hum Mol Genet. 11:2037–2049. 2002.
View Article : Google Scholar : PubMed/NCBI
|
